Clinical Trials Logo
  1. Home
  2. Frontal Fibrosing Alopecia
  3. NCT03082560

Design and Validation of a New Assessment Tool for Lichen Planopilaris

Frontal Fibrosing Alopecia Clinical Trial

Official title:
Design and Validation of a New Assessment Tool for Lichen Planopilaris, the Boston Grade of Activity in Lichen Planopilaris (Boston GOAL)

Clinical Trial Summary

The study's Primary Objective is to design and validate a grading system for objective and accurate assessment of lichen planopilaris. Secondary Objectives: - To assess change in symptoms such as pain and itch using a Numeric Rating Scale(NRS) scores and quality of life using the Dermatology Life Quality Index (DLQI) scores - To correlate this grading system with patient skin biopsies evaluating disease activity on a microscopic level - To correlate this grading system with digital global photography and trichoscopy

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03082560
Study type Observational
Source Massachusetts General Hospital
Contact
Status Active, not recruiting
Phase
Start date February 10, 2017
Completion date December 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT04409041 - Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia Phase 2
Completed NCT03630198 - Pain Outcomes Following Intralesional Corticosteroid Injections Phase 4
Enrolling by invitation NCT06202560 - Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study N/A
Not yet recruiting NCT03335228 - Platelet Rich Plasma for Frontal Fibrosing Alopecia N/A
Not yet recruiting NCT06240351 - A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA) Phase 4
Not yet recruiting NCT02467101 - Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia N/A
Recruiting NCT03422640 - Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia Phase 4
Completed NCT03346668 - Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia Early Phase 1
Completed NCT04342091 - Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling N/A
Completed NCT05332366 - A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia Phase 2